---
pmid: '26206937'
title: AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune
  dysregulation responsive to abatacept therapy.
authors:
- Lo B
- Zhang K
- Lu W
- Zheng L
- Zhang Q
- Kanellopoulou C
- Zhang Y
- Liu Z
- Fritz JM
- Marsh R
- Husami A
- Kissell D
- Nortman S
- Chaturvedi V
- Haines H
- Young LR
- Mo J
- Filipovich AH
- Bleesing JJ
- Mustillo P
- Stephens M
- Rueda CM
- Chougnet CA
- Hoebe K
- McElwee J
- Hughes JD
- Karakoc-Aydiner E
- Matthews HF
- Price S
- Su HC
- Rao VK
- Lenardo MJ
- Jordan MB
journal: Science
year: '2015'
full_text_available: false
doi: 10.1126/science.aaa1663
---

# AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
**Authors:** Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, Zhang Y, Liu Z, Fritz JM, Marsh R, Husami A, Kissell D, Nortman S, Chaturvedi V, Haines H, Young LR, Mo J, Filipovich AH, Bleesing JJ, Mustillo P, Stephens M, Rueda CM, Chougnet CA, Hoebe K, McElwee J, Hughes JD, Karakoc-Aydiner E, Matthews HF, Price S, Su HC, Rao VK, Lenardo MJ, Jordan MB
**Journal:** Science (2015)
**DOI:** [10.1126/science.aaa1663](https://doi.org/10.1126/science.aaa1663)

## Abstract

1. Science. 2015 Jul 24;349(6246):436-40. doi: 10.1126/science.aaa1663.

AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune 
dysregulation responsive to abatacept therapy.

Lo B(1), Zhang K(2), Lu W(3), Zheng L(3), Zhang Q(4), Kanellopoulou C(3), Zhang 
Y(4), Liu Z(5), Fritz JM(3), Marsh R(6), Husami A(7), Kissell D(7), Nortman 
S(7), Chaturvedi V(6), Haines H(8), Young LR(9), Mo J(10), Filipovich AH(6), 
Bleesing JJ(6), Mustillo P(11), Stephens M(12), Rueda CM(13), Chougnet CA(13), 
Hoebe K(13), McElwee J(14), Hughes JD(14), Karakoc-Aydiner E(15), Matthews 
HF(3), Price S(3), Su HC(4), Rao VK(3), Lenardo MJ(1), Jordan MB(16).

Author information:
(1)Molecular Development of the Immune System Section and Clinical and Molecular 
Genomics Unit, Laboratory of Immunology, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. NIAID 
Clinical Genomics Program, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, Bethesda, MD, USA. 
michael.jordan@cchmc.org.
(2)Division of Human Genetics, Department of Pediatrics, Cincinnati Children's 
Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA. 
michael.jordan@cchmc.org.
(3)Molecular Development of the Immune System Section and Clinical and Molecular 
Genomics Unit, Laboratory of Immunology, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. NIAID 
Clinical Genomics Program, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, Bethesda, MD, USA.
(4)NIAID Clinical Genomics Program, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, Bethesda, MD, USA. Human Immunological 
Diseases Unit, Laboratory of Host Defenses, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
(5)Lymphocyte Biology Section, Laboratory of Systems Biology, National Institute 
of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 
USA.
(6)Division of Bone Marrow Transplantation and Immune Deficiency, Department of 
Pediatrics, Cincinnati Children's Hospital Medical Center, University of 
Cincinnati, Cincinnati, OH, USA.
(7)Division of Human Genetics, Department of Pediatrics, Cincinnati Children's 
Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
(8)Division of Pediatric Hematology and Oncology, Department of Pediatrics, 
University of Alabama at Birmingham, AL, USA.
(9)Division of Allergy, Immunology, and Pulmonary Medicine, Department of 
Pediatrics, and Division of Allergy, Pulmonary, and Critical Care, Department of 
Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
(10)Departments of Pathology and Pediatrics, University of California, San Diego 
and Rady Children's Hospital, San Diego, CA, USA.
(11)Section of Allergy and Immunology, Nationwide Children's Hospital, Columbus, 
OH, USA.
(12)Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, 
MN, USA.
(13)Division of Immunobiology, Department of Pediatrics, Cincinnati Children's 
Hospital Medical Center/ University of Cincinnati, Cincinnati, OH, USA.
(14)Merck Research Laboratories, Merck & Co, Boston, MA, USA.
(15)Molecular Development of the Immune System Section and Clinical and 
Molecular Genomics Unit, Laboratory of Immunology, National Institute of Allergy 
and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. NIAID 
Clinical Genomics Program, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, Bethesda, MD, USA. Division of Human 
Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical 
Center, University of Cincinnati, Cincinnati, OH, USA. Human Immunological 
Diseases Unit, Laboratory of Host Defenses, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. 
Lymphocyte Biology Section, Laboratory of Systems Biology, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 
USA. Division of Bone Marrow Transplantation and Immune Deficiency, Department 
of Pediatrics, Cincinnati Children's Hospital Medical Center, University of 
Cincinnati, Cincinnati, OH, USA. Division of Pediatric Hematology and Oncology, 
Department of Pediatrics, University of Alabama at Birmingham, AL, USA. Division 
of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, and 
Division of Allergy, Pulmonary, and Critical Care, Department of Medicine, 
Vanderbilt University School of Medicine, Nashville, TN, USA. Departments of 
Pathology and Pediatrics, University of California, San Diego and Rady 
Children's Hospital, San Diego, CA, USA. Section of Allergy and Immunology, 
Nationwide Children's Hospital, Columbus, OH, USA. Department of Pediatrics and 
Adolescent Medicine, Mayo Clinic, Rochester, MN, USA. Division of Immunobiology, 
Department of Pediatrics, Cincinnati Children's Hospital Medical Center/ 
University of Cincinnati, Cincinnati, OH, USA. Merck Research Laboratories, 
Merck & Co, Boston, MA, USA. Marmara University, Division of Pediatric Allergy 
and Immunology, Istanbul, Turkey.
(16)Division of Bone Marrow Transplantation and Immune Deficiency, Department of 
Pediatrics, Cincinnati Children's Hospital Medical Center, University of 
Cincinnati, Cincinnati, OH, USA. Division of Immunobiology, Department of 
Pediatrics, Cincinnati Children's Hospital Medical Center/ University of 
Cincinnati, Cincinnati, OH, USA. michael.jordan@cchmc.org.

Comment in
    Science. 2015 Jul 24;349(6246):377-8. doi: 10.1126/science.aac7888.
    Oral Dis. 2016 May;22(4):249-50. doi: 10.1111/odi.12455.

Mutations in the LRBA gene (encoding the lipopolysaccharide-responsive and 
beige-like anchor protein) cause a syndrome of autoimmunity, 
lymphoproliferation, and humoral immune deficiency. The biological role of LRBA 
in immunologic disease is unknown. We found that patients with LRBA deficiency 
manifested a dramatic and sustained improvement in response to abatacept, a 
CTLA4 (cytotoxic T lymphocyte antigen-4)-immunoglobulin fusion drug. Clinical 
responses and homology of LRBA to proteins controlling intracellular trafficking 
led us to hypothesize that it regulates CTLA4, a potent inhibitory immune 
receptor. We found that LRBA colocalized with CTLA4 in endosomal vesicles and 
that LRBA deficiency or knockdown increased CTLA4 turnover, which resulted in 
reduced levels of CTLA4 protein in FoxP3(+) regulatory and activated 
conventional T cells. In LRBA-deficient cells, inhibition of lysosome 
degradation with chloroquine prevented CTLA4 loss. These findings elucidate a 
mechanism for CTLA4 trafficking and control of immune responses and suggest 
therapies for diseases involving the CTLA4 pathway.

Copyright Â© 2015, American Association for the Advancement of Science.

DOI: 10.1126/science.aaa1663
PMID: 26206937 [Indexed for MEDLINE]
